Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%

In a landmark development, global biopharmaceutical company Sanofi
will lower the price of Rifapentine, a critically important drug used
to prevent tuberculosis (TB), as part of the agreement with Unitaid,
the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official
release said on Thursday.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanofi-inks-pact-with-unitaid-to-reduce-tb-drug-rifapentine-price-by-70/articleshow/71836241.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment